Key statistics
As of last trade, Perspective Therapeutics Inc (AAJ0:BER) traded at 2.80, 30.84% above the 52 week low of 2.14 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.80 |
---|---|
High | 2.80 |
Low | 2.80 |
Bid | 3.20 |
Offer | 3.22 |
Previous close | 5.75 |
Average volume | 132.56 |
---|---|
Shares outstanding | 67.43m |
Free float | 53.52m |
P/E (TTM) | -- |
Market cap | 202.28m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:08 GMT.
More ▼
- Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
- Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
- Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
- Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
- Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
- Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day
- Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine
More ▼